Vai al contenuto principale della pagina

Improving drug pricing transparency and lowering prices for American consumers : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 21, 2019



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Titolo: Improving drug pricing transparency and lowering prices for American consumers : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 21, 2019 Visualizza cluster
Pubblicazione: Washington : , : U.S. Government Publishing Office, , 2021
Descrizione fisica: 1 online resource (vi, 187 pages) : color illustrations
Soggetto topico: Drugs - Prices - United States
Pharmaceutical industry - United States
Prescription pricing - United States
Prescription pricing - Law and legislation - United States
Insurance premiums - Law and legislation - United States
Soggetto genere / forma: Legislative hearings.
Note generali: Access ID (govinfo): CHRG-116hhrg40555.
"Serial no. 116-37."
Nota di bibliografia: Includes bibliographical references.
Altri titoli varianti: Improving drug pricing transparency and lowering prices for American consumers
Titolo autorizzato: Improving drug pricing transparency and lowering prices for American consumers  Visualizza cluster
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910716543703321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui